On March 27, 2024, Ann & Robert H. Lurie Children's Hospital of Chicago treated its first patient with ELEVIDYS (delandistrogene moxeparvovec-rokl), the first gene therapy for Duchenne muscular dystrophy – a rare, genetic disease characterized by progressive muscle damage and weakness.
Animal mutations include extra heads and legs never seen before in history. Click to read more. Animal mutations may seem to be in the field of science fiction.
Lung cancer is the leading cause of cancer-related death worldwide. Improved understanding of driver mutations of non-small cell lung cancer (NSCLC) has led to more biomarker-directed treatment for patients with advanced stages.
New study unveils a significant connection between oral bacteria and pancreatic cancer development in mice and sheds light on a previously recognized link between oral health and pancreatic cancer, one of the deadliest forms of cancer.